150168-54-0 = 86386-73-4 反应条件:1.1 Reagents: Sodium Nitrite,Hydrochloric Acid Solvents: Water 标题:Preparation Of Fluconazole 参考文献:Canada]
86386-76-7 + 288-88-0 = 86386-73-4 反应条件:1.1 Reagents: Triethylamine Solvents: Ethanol; 24 H,80 °C 标题:Visible-Light-Induced Regioselective Radical Oxo-Amination Of Alkenes With O2 As The Oxygen Source 作者:Wang,Jiayang; Et Al 参考文献:Organic Letters 日期:2023 卷标:25(28) 页码:5333-5338]
288-88-0 + 86386-74-5 = 86386-73-4 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Dimethylformamide; 1 H,Reflux1.2 Solvents: Dimethylformamide; 16 H,Reflux 标题:An Improved Method For The Addition Reactions Of 1,3-Dichloroacetone With Combined Organolithium-Cerium Trichloride Reagents 作者:Chen,Same-Ting; Et Al 参考文献:Journal Of The Chinese Chemical Society (Taipei 日期:2003 卷标:50(4) 页码:927-930]
86386-73-4 + 75-75-2 = 86386-73-4 反应条件:1.1 Reagents: 4-Amino-1,2,4-Triazole Solvents: Isopropanol1.2 Reagents: Sodium Nitrite,Hydrochloric Acid Solvents: Water 标题:Process For The Preparation Of Antimycotic 1,3-Bis(1,2,4-Triazol-1-Yl)Propan-2-Ol Derivatives From Aminotriazole And Triazolylmethyl-Substituted Oxiranes. 参考文献:European Patent Organization]
5034-06-0 + 288-88-0 + 51336-94-8 = 86386-73-4 反应条件:1.1 Solvents: N-Methyl-2-Pyrrolidone; 48 Min,Rt -> 130 °C1.2 Reagents: Potassium Hydroxide Solvents: Water; 48 Min,130 °C -> 110 °C 标题:Fully Automated Chemical Synthesis: Toward The Universal Synthesizer 作者:Collins,Nathan; Et Al 参考文献:Organic Process Research & Development 日期:2020 卷标:24(10) 页码:2064-2077]
290-87-9 = 86386-73-4 反应条件:1.1 Reagents: Formic Acid,Trifluoroacetic Acid Solvents: Acetonitrile 标题:Process For Preparing Biologically Active Derivatives Of 1,2,4-Triazole,Particularly Fluconazole,And Intermediates Useful In This Process 参考文献:World Intellectual Property Organization]
1774-47-6 + 288-88-0 + 86404-63-9 = 86386-73-4 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Dimethylformamide,Water; 3 H,90 °C1.2 Reagents: Sodium Carbonate; Rt -> 90 °C; 3 H,90 °C 标题:Optimization And Study On The Synthesis Of Fluconazole 作者:Wu,Chunli; Et Al 参考文献:Zhongguo Yaowu Huaxue Zazhi 日期:2011 卷标:21(4) 页码:304-307]
288-88-0 + 86386-74-5 = 86386-73-4 反应条件:1.1 Reagents: Sodium Carbonate Solvents: Methanol,Water; 15 Min,Rt; Rt -> 60 °C1.2 4.5 H,60 °C 标题:The Application Of A Continuous Grignard Reaction In The Preparation Of Fluconazole 作者:Korwar,Sudha; Et Al 参考文献:European Journal Of Organic Chemistry 日期:2017 卷标:2017(44) 页码:6495-6498]
288-88-0 + 86386-74-5 = 86386-73-4 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Toluene; 3 H,90 °C 标题:Synthesis And Crystal Structure Of [α-(2,4-Difluorophenyl)- α-(1H-1,2,4-Triazole-1-Ylmethyl)-1H-1,2,4-Triazole-1-Ethanol]Cu(Ii) Complex 作者:Wang,Yongfen; Et Al 参考文献:Asian Journal Of Chemistry 日期:2014 卷标:26(24) 页码:8593-8595]
86386-76-7 + 288-88-0 + 75-75-2 = 86386-73-4 反应条件:1.1 Reagents: Sodium Carbonate; 10 Min 标题:Rapid Synthesis Of Some New Propanol Derivatives Analogous To Fluconazole Under Microwave Irradiation In A Solventless System 作者:Heravi,Majid M.; Et Al 参考文献:Heterocyclic Communications 日期:2005 卷标:11(1) 页码:19-22]
5034-06-0 + 288-88-0 + 51336-94-8 = 86386-73-4 反应条件:1.1 Solvents: N-Methyl-2-Pyrrolidone; 97 Min,Rt -> 130 °C1.2 Reagents: Potassium Hydroxide Solvents: Water; 48 Min,Rt -> 110 °C 标题:Multi-Step Continuous Flow Synthesis Of Fluconazole 作者:Szeto,Judy; Et Al 参考文献:Journal Of Flow Chemistry 日期:2019 卷标:9(1) 页码:35-42
(S,R)-2-(2,4-Difluorophenyl)-1,3-Bis-(1H-1,2,4-Triazol-1-yl)-2,3-Epoxypropane置于sodium Hydroxide,二异丁基氢化铝体系中,用 二氯甲烷 作为反应溶剂,化学反应生成 氟康唑 参考文献:Process For The Manufacture Of Bis-Triazole Compounds And Intermediates 标题:Process For The Manufacture Of Bis-Triazole Compounds And Intermediates 摘要:本发明涉及一种制备式(i)化合物的过程,其中y和z可以相同或不同,且表示卤素.式(i)的双三唑化合物和中间体具有抗真菌活性.
专利号:US-12383499-B2 优先权日:2018-01-01 标题:Scale up synthesis of silicasome nanocarriers 发明人:NEL ANDRE E; MENG HUAN; LIU XIANGSHENG 权利人:UNIV CALIFORNIA 摘要:In order to facilitate the approval and commercialization of silicasome drug delivery systems (e.g. irinotecan silicasomes) it is necessary to scale up synthesis of the drug-loaded silicasomes. In this regard, it was discovered that the synthesis protocols used for laboratory synthesis of drug-loaded silicasomes (e.g., 500 mg/batch) do not scale to large scale silicasome production, because the resulting products were too heterogeneous for use as pharmaceuticals. Accordingly, new methods are provided herein that effectively afford the large-scale production of mesoporous silica nanoparticles (MSNPs) and lipid bilayer coated MSNPs (silicasomes).
专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-10308663-B2 优先权日:2015-06-16 标题:Inhibitors of PTP4A3 for the treatment of cancer 发明人:LAZO JOHN S; SHARLOW ELIZABETH R; MCQUEENEY KELLEY E; WIPF PETER; SALAMOUN JOSEPH M 权利人:LAZO JOHN S; SHARLOW ELIZABETH R; MCQUEENEY KELLEY E; WIPF PETER; SALAMOUN JOSEPH M; UNIV VIRGINIA PATENT FOUNDATION; UNIV OF PITTSBURGH —OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 摘要:The invention provides protein tyrosine phosphatase inhibitor compounds, Their pharmaceutical compositions, uses, and methods of use, such as in the treatment of various cancers, and process for making the compounds. Also disclosed is an improved synthesis of protein tyrosine phosphatase inhibitor and precursor compound thienopyridone (5).
专利号:US-9464108-B2 优先权日:2012-03-15 标 题:Combined synthesis route for desogestrel and etonogestrel 发明人:OSTENDORF MARTIN 权利人:MSD OSS BV; MERCK SHARP & DOHME 摘要:The present invention relates to a synthesis route and to steroid derivatives of general formula VI and VII useful in the synthesis of desogestrel and etonogestrel.
专利号:US-8742013-B2 优先权日:2009-04-24 标 题:Synthesis of lipoamide-grafted high molecular compound and method therefor 发明人:NOH INSUP; JO SEONGYEUN; KIM DOYEON; WOO JUNGHOON 权利人:NOH INSUP; JO SEONGYEUN; KIM DOYEON; WOO JUNGHOON; NAT UNIV SEOUL TECH CTENTER 摘要:The present disclosure provides polymer compounds binding with lipoamide produced by the reaction of the primary amine group of lipoamide with the carboxy group of polysaccharide compounds such as chondroitin sulfates, carboxymethyl celluloses, or hyaluronic acids; functional compounds such as peptides, proteins, growth factors; or drugs; or biocompatible polymers such as poly(ethylene oxide), poly(vinyl alcohol), or poly(vinyl pyrrolidone). The present disclosure also provides their synthesis methods, products of hydrogels and films using the same as and methods for manufacturing the products.
专利号:US-8557979-B2 优先权日:2004-06-10 标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation 发明人:CHOI WOO-BAEG; KOWALIK EWA 权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC 摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.
1: Eschenauer GA, Nguyen MH, Clancy CJ. Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia. Ann Pharmacother. 2015 Sep;49(9):1068-74. doi: 10.1177/1060028015590838. Epub 2015 Jun 23. Review. doi: 10.1038/jp.2014.92. Review. doi: 10.1002/14651858.CD000239.pub2. Review. doi: 10.1007/s10096-014-2074-2. Epub 2014 Feb 20. Review. Review. doi: 10.1016/j.ijantimicag.2013.12.009. Epub 2014 Jan 22. Review. doi: 10.1097/MOP.0000000000000060. Review. 8: Jørgensen KJ, Gøtzsche PC, Dalbøge CS, Johansen HK. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Cochrane Database Syst Rev. 2014 Feb 24;2:CD004707. doi: 10.1002/14651858.CD004707.pub3. Review. doi: 10.2147/TCRM.S47146. eCollection 2014. Review. 10: Egunsola O, Adefurin A, Fakis A, Jacqz-Aigrain E, Choonara I, Sammons H. Safety of fluconazole in paediatrics: a systematic review. Eur J Clin Pharmacol. 2013 Jun;69(6):1211-21. doi: 10.1007/s00228-012-1468-2. Epub 2013 Jan 17. Review.
合成参考文献
参考文献:10.2166/wh.2009.170 摘要:Brandão LR, Medeiros AO, Duarte MC, Barbosa AC, Rosa CA. Diversity and antifungal susceptibility of yeasts isolated by multiple-tube fermentation from three freshwater lakes in Brazil. J Water Health. 2010 Jun;8(2):279–89. doi: 10.2166/wh.2009.170. 参考文献:10.1007/s10266-009-0118-3 摘要:Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010 Feb;98(1):15–25. doi: 10.1007/s10266-009-0118-3. 参考文献:10.1097/01.mog.0000196149.29077.0d 摘要:Thom K, Forrest G. Gastrointestinal infections in immunocompromised hosts. Curr Opin Gastroenterol. 2006 Jan;22(1):18–23. doi: 10.1097/01.mog.0000196149.29077.0d. 参考文献:10.2165/11319380-000000000-00000 摘要:Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf. 2010 Mar 01;33(3):171–87. doi: 10.2165/11319380-000000000-00000. 参考文献:10.1001/archophthalmol.2011.184 摘要:Mayercik VA, Eller AW, Pihlblad MS. Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. Arch Ophthalmol. 2011 Jul;129(7):952–3. doi: 10.1001/archophthalmol.2011.184.